ESC 365 - Impact of beta-blocker carvedilol versus Bisoprolol prescription at discharge on long-term clinical outcomes in STEMI patients with preserved LVEF treated with drug-eluting stents

ESC Professional Premium Access

Impact of beta-blocker carvedilol versus Bisoprolol prescription at discharge on long-term clinical outcomes in STEMI patients with preserved LVEF treated with drug-eluting stents

Session: Pharmacotherapy in acute coronary syndromes (5)

Topic: ST-Elevation Myocardial Infarction (STEMI)

Speaker: Doctor S. Park (Seoul, KR)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Soohyung Park

Korea University Guro Hospital, Seoul (Korea (Republic of))

0 follower

3 more presentations in this session

Prophylactic anticoagulation for left ventricular thrombus in patients with anterior myocardial infarction

Speaker: Doctor A. Gajulapalli (Stony Brook, US)

High-intensity lipid-lowering therapy accelerates early plaque regression: a FLOWPROMOTE sub study.

Speaker: Doctor N. Iraqi (Aarhus, DK)

Efficacy and safety of potent p2y12 inhibitors versus clopidogrel in complex percutaneous coronary intervention: a systematic review and meta-analysis

Speaker: Doctor F. Stabile (Palermo, IT)

Access the full session

Pharmacotherapy in acute coronary syndromes (5)

Speakers: Doctor S. Park, Doctor A. Gajulapalli, Doctor N. Iraqi, Doctor F. Stabile

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

novartis

Explore sponsored resources